Target Name: LOC112267902
NCBI ID: G112267902
Review Report on LOC112267902 Target / Biomarker Content of Review Report on LOC112267902 Target / Biomarker
LOC112267902
Other Name(s): LOC112267902 variant X2 | Uncharacterized LOC112267902, transcript variant X2 | uncharacterized LOC112267902

LOC112267902: A Potential Drug Target for Intracellular Signaling and Tissue Repair

LOC112267902 is a protein that is expressed in various tissues of the body, including the brain, heart, and liver. It is a member of the LOC112 family of proteins, which are known for their role in intracellular signaling. LOC112267902 has been shown to play a role in the regulation of cell proliferation and has been identified as a potential drug target in several diseases.

The LOC112 family of proteins was identified through a combination of genetic and biochemical studies. The protein encoded by the LOC112267902 gene is a 21 kDa protein that is expressed in a variety of tissues, including the brain, heart, and liver. It is highly conserved, with a calculated pI of 5.6 and a predicted hydration state of 12.9 kDa.

The LOC112267902 protein is involved in several intracellular signaling pathways, including the regulation of cell growth, differentiation, and survival. It has been shown to play a role in the regulation of cell proliferation, differentiation, and survival in a variety of tissues and organs. For example, LOC112267902 has been shown to be involved in the regulation of the growth and differentiation of cancer cells.

In addition to its role in intracellular signaling, LOC112267902 has also been shown to play a role in the regulation of tissue repair and regeneration. It has been shown to play a role in the regulation of the growth and differentiation of stem cells and has been shown to be involved in the regulation of tissue repair and regeneration after injury or disease.

As a potential drug target, LOC112267902 has been the subject of intense research due to its involvement in several diseases. LOC112267902 has been shown to be involved in the regulation of cancer cell growth and has been identified as a potential target for a variety of cancer therapies, including inhibitors of the PI3K/Akt signaling pathway, which is involved in cancer cell survival and proliferation.

In addition to its potential as a cancer therapeutic, LOC112267902 has also been shown to have potential applications in the treatment of other diseases. For example, it has been shown to play a role in the regulation of inflammation and has been identified as a potential target for the treatment of autoimmune diseases. Additionally, LOC112267902 has been shown to play a role in the regulation of cellular signaling pathways that are involved in the regulation of eye development and function, which has led to its potential as a therapeutic target for diseases such as age-related macular degeneration and blindness.

In conclusion, LOC112267902 is a protein that has been shown to play a role in several intracellular signaling pathways and has potential applications as a drug target in a variety of diseases. Further research is needed to fully understand the role of LOC112267902 in intracellular signaling and its potential as a therapeutic target.

Protein Name: Uncharacterized LOC112267902

The "LOC112267902 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC112267902 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC112267956 | LOC112267962 | LOC112267968 | LOC112267978 | LOC112268051 | LOC112268136 | LOC112268248 | LOC112268286 | LOC112268294 | LOC112268416 | LOC114224 | LOC123862 | LOC124901339 | LOC126987 | LOC129026 | LOC132386 | LOC143666 | LOC145474 | LOC145845 | LOC148430 | LOC148696 | LOC149351 | LOC149684 | LOC151760 | LOC153893 | LOC153910 | LOC154449 | LOC154761 | LOC155060 | LOC157273 | LOC158434 | LOC158435 | LOC158696 | LOC162137 | LOC202181 | LOC221946 | LOC254896 | LOC260339 | LOC283028 | LOC283038 | LOC283045 | LOC283070 | LOC283194 | LOC283278 | LOC283299 | LOC283683 | LOC283731 | LOC283788 | LOC284009 | LOC284191 | LOC284240 | LOC284344 | LOC284379 | LOC284412 | LOC284581 | LOC284600 | LOC284788 | LOC284798 | LOC284898 | LOC284950 | LOC285097 | LOC285232 | LOC285626 | LOC285762 | LOC285819 | LOC285847 | LOC285889 | LOC286059 | LOC286083 | LOC286177 | LOC286297 | LOC286359 | LOC286437 | LOC338694 | LOC339059 | LOC339166 | LOC339260 | LOC339352 | LOC339593 | LOC339666 | LOC339685 | LOC339760 | LOC339975 | LOC340090 | LOC340184 | LOC340512 | LOC343052 | LOC344967 | LOC349160 | LOC374443 | LOC375196 | LOC387720 | LOC388242 | LOC388780 | LOC389199 | LOC389473 | LOC389765 | LOC389831 | LOC389834 | LOC389895